Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.21.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 46 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Operating Activities:          
Net loss     $ (19,310) $ (6,242)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization [note 3]     127 126  
Stock-based compensation [note 6 [c] and note 6 [d]] $ 621 $ 308 1,163 610  
Shares issued as settlement with trade vendor     41    
Changes in operating assets and liabilities:          
Amounts receivable       8  
Prepaid expenses and other assets     702 (142)  
Accounts payable     243 (336)  
Accrued liabilities other     (391) 10  
Accrued clinical liabilities     2,585 (314)  
Accrued compensation     (680) (381)  
Lease obligation [note 7]     (8) 2  
Net cash used in operating activities     (15,528) (6,659)  
Financing Activities:          
Proceeds from exercise of warrants     331 589  
Net cash provided by financing activities     21,674 2,120  
Investing Activities:          
Purchase of property and equipment       (14)  
Net cash used in investing activities       (14)  
Effect of exchange rate changes on cash     2    
Net increase (decrease) in cash, cash equivalents and restricted cash     6,148 (4,553)  
Cash, cash equivalents and restricted cash at beginning of the period     35,903 16,714  
Cash, cash equivalents and restricted cash at end of the period $ 42,051 $ 12,161 42,051 12,161 $ 42,051
April 2020 Private Placement [Member]          
Financing Activities:          
Proceeds financing and purchase agreement, net of issuance costs       1,579  
December 2019 Public Offering [Member]          
Financing Activities:          
Financing costs relating to public offering and purchase agreement       (34)  
May 2021 Public Offering [Member]          
Financing Activities:          
Proceeds from offering, net of issuance costs     $ 21,343    
LPC [Member]          
Financing Activities:          
Financing costs relating to public offering and purchase agreement         $ (500)
LPC [Member] | Purchase Agreement [Member]          
Financing Activities:          
Financing costs relating to public offering and purchase agreement       $ (14)